SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-028254
Filing Date
2017-04-26
Accepted
2017-04-26 18:27:53
Documents
2
Period of Report
2017-04-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1602
2 POA DOCUMENT poa.txt EX-24.3_719586 3265
  Complete submission text file 0001209191-17-028254.txt   6234
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Issuer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 257 SIMARANO DRIVE, SUITE 101 MARLBOROUGH MA 01752
Business Address
Dispersyn Gerrit (Reporting) CIK: 0001704417 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36304 | Film No.: 17785702